ꢀ
N. Smrecki et al. / Journal of Organometallic Chemistry 760 (2014) 224e230
225
Besides their catalytic aspects, palladium(II) compounds exhibit
inherent cytotoxic behavior. On the basis of the structural analogy
(d8 ions in a square-planar geometry) and the thermodynamic
difference with platinum(II) complexes, there is much interest in
the study of palladium(II) complexes as potential anticancer drugs,
especially those bearing the chelating ligands [18e22].
Here we report the preparation, spectroscopic (IR and NMR) and
thermal characterization of five new palladium(II) complexes with
N-arylalkyliminodiacetate ligands as well as their antitumor
properties and catalytic activity (Scheme 1). The crystal structure of
the complex 1a is also reported.
1.68(29.2) NCH2CH2CH2Ar; 2.57(32.6) NCH2CH2CH2Ar; (142.0) Ci,
7.19(128.2) ortho, 7.26(128.2) meta, 7.16(125.6) para, Ar;
15N: ꢀ353.1 ppm; o-H2Cbida: 1H(13C) [ppm]: 3.46(53.9) CH2CO2H;
(172.3) CO2H; 3.96(54.2) CH2Ar; (132.9) Ci, 7.63(130.5), (136.4) ortho,
7.28(127.1), 7.41(129.1) meta, 7.23(128.6) para Ar; 15N: ꢀ353.1 ppm.
The samples have been measured about one hour after dissolution. In
a few days, the samples slowly decomposed in DMSO solutions.
2.2. Synthesis of the complexes
An aqueous solution of Na2PdCl4$xH2O (x z 3), (0.18 g; 0.5 mmol
in 20 mL) was added to a hot solution containing 1 mmol of the
appropriate ligands H2Bnida, H2Peida, H2Ppida and o-H2Cbida
(Bn ¼ benzyl, Pe ¼ 2-phenylethyl; Pp ¼ 3-phenylprop-1-yl; o-
Cb ¼ o-chlorobenzyl) and 0.04 g (1 mmol) NaOH in 25 mL of water.
The resulting yellow solution was left to stand at room temperature
for 48 h in case of complex 1a (the crystallization starts few hours
after mixing of the reactants) or overnight in case of the complexes
2e4 (2 crystallizes after few minutes, while 3 and 4 precipitate
immediately). The complexes were filtered off by suction, washed
with water (5 mL for 1a, 15 mL for 2e4) and dried. Complex 1a was
dried by standing in air for a few hours, while 2e4 were dried first
by standing in air for a few days and then in a desiccator over
anhydrous CaCl2. Drying the sample of 1a in a desiccator over solid
KOH at room temperature for one week gave [Pd(HBnida)2] (1b). The
complexes are soluble in dimethyl sulfoxide and N,N-dime-
thylformamide but almost insoluble in water and pyridine.
2. Experimental
2.1. Materials and physical measurements
Sodium hydroxide and Na2PdCl4$xH2O (x z 3), containing 30% Pd
by weight, were purchased from Alfa Aesar and used as received
without further purification. The ligands were prepared as reported
earlier [1]. CHN analyses were performed on PerkineElmer 2400
Series II CHNS analyzer in the Analytical Services Laboratories of the
ꢀ
ꢁ
RuCer Boskovic Institute, Zagreb, Croatia. The IR spectra were ob-
tained from KBr pellets in the range 4000e450 cmꢀ1 with Perkine
Elmer Spectrum RXI FTIR-spectrometer. TGA/DTA measurements
were performed at heating rate of 10 ꢁC minꢀ1 in the temperatuꢀre1
range of 25 e 600 ꢁC, under nitrogen or oxygen flow of 20 mL min
on instrument Mettler-Toledo TGA/SDTA 851e. Approximately 10 mg
of sample were placed in standard aluminum crucible (40 mL). All
[Pd(HBnida)2]$2H2O (1a). From 0.23 g H2Bnida. Yellow crystals;
yield: 0.19 g (64%). After w2 weeks, yellow prismatic crystals of 1a
(0.05 g; 17%), suitable for X-ray structural analysis, were obtained
by the slow evaporation of the filtrate. Total yield 82%. Anal. Calc.
for C22H28N2O10Pd (586.89): C, 45.02; H, 4.81; N, 4.77%. Found: C,
46.02; H, 4.84; N, 5.08%. The assigned IR data (cmꢀ1): 3586(s)
NMR measurements were performed on a Bruker DRX AVANCE 500
spectrometer equipped with a 5 mm triple broadband inverse probe
(TBI) with a z-gradient coil, and a Varian-NMR-vnmrs 600 spec-
trometer equipped with a 600 MHz PFGAuto XID (1H/15Ne31P 5 mm)
indirect probe. The measurements were carried out in DMSO-d6 so-
lutions, at the room temperature (303 K), using typical parameter
values. Residual solvent signals were used as the secondary refer-
ences, assuming 2.49 ppm (1H) and 39.5 ppm (13C) with respect to the
TMS signal (0 ppm). Typically, a set of 1H NMR,13C NMR, and 13C,1H g-
HSQC and HMBC spectra were obtained. The nitrogen-15 chemical
shifts were obtained from 15N,1H g-HMBC spectra, optimized for
nJ(1H,15N) of 3, 6, or 8 Hz, depending on the sample. The nitrogen
chemical shifts were given with respect to CH3NO2 (0 ppm). The
1H(13C) and 15N NMR chemical shifts of starting ligands (ppm) are
given below: H2Bnida: 1H(13C) [ppm]: 3.41(53.6) CH2CO2H; (172.3)
CO2H; 3.83(57.1) CH2Ar; (138.7) Ci, 7.35(128.7, 128.2) ortho, meta,
7.26(127.1) para Ar; 15N: ꢀ349.1 ppm; H2Peida: 1H(13C) [ppm]:
3.49(54.6) CH2CO2H; (172.4) CO2H; 2.88(55.8) NCH2CH2Ar;
2.72(33.7) NCH2CH2Ar; (139.9) Ci, 7.21(128.2) ortho, 7.27(128.6) meta,
7.18(129.9) para Ar; 15N: ꢀ350.1 ppm; H2Ppida: 1H(13C) [ppm]:
3.43(54.8) CH2CO2H; (172.4) CO2H; 2.67(53.5) NCH2CH2CH2Ar;
(n
(OH) of H2O); w3370(m, broad), 1718(s), 1231(m), 709(w) (
n
(OH),
n
(C]O), (OH) and
d
p(OH) of COOH); 1628(vs) and 1358(m) (nas and
ns of COOꢀ). Other IR data (cmꢀ1): 2932(w), 2711(w), 2602(w),
2515(w), 2365(w), 1942(w, br), 1494(w), 1459(w), 1434(w),
1418(w), 1319(m), 1288(w), 1114(w), 1084(w), 1065(w), 994(w),
964(w), 949(w), 921(m), 898(w), 871(w), 779(w), 751(w), 669(w),
636(w), 598(w), 571(w), 573(w).
[Pd(HBnida)2] (1b). The assigned IR data (cmꢀ1): w3450 (m,
broad), 1736(vs), 1216(s), 698(m) (n(OH), n(C]O), d(OH) and p(OH)
of COOH); 1612(vs) and 1380(vs) (nas and ns of COOꢀ). Other IR data
(cmꢀ1): 2928(m), 2744(m), 2674(m), 2598(m), 2534(m), 1494(w),
1456(w), 1416(m), 1326(m), 1260(m), 1112(m), 1084(w), 1050(w),
1026(m), 964(m), 932(m), 892(m), 872(m), 748(m), 636(w),
588(w), 558(w), 524(w), 502(w). 1H(13C) NMR (
d, ppm; J, Hz): 3.15,
3.66 (56.1), 2J 17.6 Hz CH2 (het. ring); (168.9) (het. ring); 3.37, 4.36
(63.3), 2J 15.9 CH2CO2H; (176.7) CO2H; 3.80, 4.03 (64.0), 2J 12.5
NCH2Ar; (132.3) Ci, 8.21(132.4) ortho, 7.49(128.5) meta, 7.43(129.1)
para, Ar. The main to secondary product molar ratio: 1:0.16.
[Pd(HPeida)2] (2). From 0.24 g H2Peida. Yellow crystals; yield:
0.27 g (93%). Anal. Calc. for C24H28N2O8Pd (578.88): C, 49.79; H,
4.88; N, 4.84%. Found: C, 49.87; H, 5.06; N, 4.82%. The assigned IR
data (cmꢀ1): w3450(w, broad), 1731(vs), 1216(s), 701(m) (
n
(OH),
n
(C]O), d(OH) and p(OH) of COOH); 1604(vs) and 1370(s) (nas and
ns of COOꢀ). Other IR data (cmꢀ1): 3026(w), 2930(m), 2870(m),
2534(w), 2367(w), 1496(w), 1456(m), 1436(w), 1416(w), 1327(m),
1259(m), 1114(m), 1076(w), 1033(w), 996(w), 884(broad, m),
826(w), 754(m), 625(w), 584(w), 546(w), 522(w), 500(w), 481(w).
1H(13C) NMR ( , ppm; J, Hz): 3.33, 3.72 (58.2), 2J 17.3 Hz CH2 (het.
d
ring); (169.3) (het. ring); 3.31, 4.07 (62.7), 2J 16.5 CH2CO2H; (178.2)
CO2H; 2.89 (63.5) NCH2CH2Ar; 3.49, 3.92 (32.7) NCH2CH2Ar; (138.1)
Ci, 7.48(129.1) ortho, 7.33 (128.6) meta, 7.28 (126.5) para, Ar.
Scheme 1. Methoxycarbonylation of iodobenzene with methanol catalyzed by the
palladium(II) complexes 1e4.